• leader board size

Insights

Controversy Arises Over Ohio’s New Cannabis Control Superintendent Appointment

LOS ANGELES- Ohio's recent strides towards cannabis legalization have been met with a mix of anticipation and concern, particularly following the appointment of James V. Canepa as the first Superintendent of the Division of Cannabis Control. This decision has sparked debate among industry experts, activists, and the public, raising questions about the state's commitment to progressive ...

December 22nd, 2023|

Minnesota Health Officials Caution Against Illegal High-Potency Hemp Products

LOS ANGELES- The Minnesota Department of Health has issued an urgent warning to consumers regarding the sale of unregulated and illegal cannabis products that exceed the state's THC potency limits. Despite legalizing recreational cannabis earlier this year, Minnesota does not expect state-licensed cannabis dispensaries to open until possibly early 2025, leaving a regulatory gap that ...

December 22nd, 2023|

California Attorney General Warns of Federal Risks in Interstate Cannabis Commerce

LOS ANGELES- California Attorney General Rob Bonta has recently raised significant concerns over the potential federal legal risks involved in initiating interstate cannabis commerce. This issue has become a pivotal point of discussion following the enactment of a law by Gov. Gavin Newsome last year, which authorized state-licensed cannabis companies to export their products to ...

December 22nd, 2023|

Psychedelics Regulatory Maze: Navigating the State-Federal Conundrum

The expanding legalization of psychedelics for medical and therapeutic uses across various states in the United States is stepping into a complex regulatory terrain, one previously charted by the cannabis industry. This emerging scenario raises critical questions about the interplay between state autonomy and federal oversight in drug regulation. The issue hinges on the divergent ...

December 20th, 2023|

Numinus and Cedar Clinical Research Join Beckley Psytech’s Phase 2b Psychedelic Trial for Depression

Numinus Wellness Inc. recognized for approach to mental health care, has announced a significant milestone in psychedelic-assisted therapies. Its research arm, Cedar Clinical Research (CCR), has been selected as a pivotal site for a groundbreaking Phase 2b clinical trial by Beckley Psytech, focusing on Treatment Resistant Depression (TRD). This study is designed to assess the ...

December 19th, 2023|

Regulatory Hurdles Challenge Social Equity Cannabis Licensing in Missouri

LOS ANGELES- In a significant development impacting Missouri's cannabis industry, nearly one-quarter of the 48 social equity cannabis microbusiness permits awarded in October have been declared ineligible by the Department of Health and Senior Services (DHSS). The 11 affected applicants, encompassing permits for nine dispensaries and two wholesalers, face the loss of their licenses. This ...

December 19th, 2023|

Nebraska Medical Cannabis Initiative Gains Momentum Amid Opposition

LOS ANGELES- In Nebraska, a significant movement is underway as the group Nebraskans for Medical Marijuana (NMM) intensifies its efforts to gather signatures for two pivotal medical cannabis legalization initiatives aimed for the 2024 ballot. This drive highlights a growing grassroots movement in the state, reflecting a broader national dialogue on cannabis legalization. To secure ...

December 19th, 2023|

MindMed Announces Promising Results from Phase 2b Trial of MM-120 for Generalized Anxiety Disorder

LOS ANGELES- Mind Medicine (MindMed) Inc, a biotech company focusing on psychedelic-inspired therapies, recently revealed encouraging topline results from its Phase 2b clinical trial of MM-120 (lysergide d-tartrate) in treating Generalized Anxiety Disorder (GAD). The trial's success is significant, as it met its primary endpoint with MM-120 showing statistically significant improvements in anxiety symptoms compared ...

December 18th, 2023|

Sunstone Therapies Reports Breakthrough in Psilocybin-Assisted Therapy for Cancer Patients with Depression

LOS ANGELES- Sunstone Therapies, a organization in psychedelic-assisted therapy, recently announced notable findings from its phase 2 clinical trial, published in the journal Cancer. This trial marks a significant step in understanding the potential of psilocybin, a psychedelic compound, in treating major depressive disorder (MDD) among cancer patients. The study, an open-label trial, involved administering ...

December 18th, 2023|

CSU’s Institute of Cannabis Research Invests $800,000 in Groundbreaking Studies

LOS ANGELES- The Institute of Cannabis Research (ICR) at Colorado State University (CSU), Pueblo, has announced a significant investment in cannabis research, earmarking $800,000 for six pioneering studies. This initiative, funded through the Colorado Marijuana Tax Cash Fund since 2019, underscores Colorado's commitment to advancing scientific understanding of cannabis and its impacts. These studies, conducted ...

December 18th, 2023|

Colorado’s MED Prepares for Future of Cannabis Inventory Tracking

LOS ANGELES- The Colorado Marijuana Enforcement Division (MED) is at a pivotal juncture in its oversight of the state's cannabis industry. Since the legalization of recreational cannabis in 2012, the MED has played a crucial role in ensuring compliance and safety standards, notably through the use of Radio Frequency Identification (RFID) METRC tags for inventory ...

December 17th, 2023|

Trulieve Alabama Recognized as Minority-Owned Business

LOS ANGELES- The Alabama Medical Cannabis Commission (AMCC) has recently taken a significant step forward in the development of the state's medical cannabis industry. In a pivotal move, the AMCC awarded integrated licenses to five companies, marking a crucial phase in the implementation of the medical marijuana law passed in 2021 in Alabama. This development ...

December 17th, 2023|

Cannabis Bioscience International Holdings (CBIH) Announces SEC Approval for Common Stock Sale

LOS ANGELES- Cannabis Bioscience International Holdings (CBIH), a prominent player in the cannabis bioscience sector, announced on Friday a significant milestone in its financial journey. The company's registration statement on Form S-1, under the Securities Act of 1933, was declared effective by the United States Securities and Exchange Commission (SEC) on December 5. This pivotal ...

December 15th, 2023|

Beckley Academy Strengthens Psychedelic Therapy Training Team with New Facilitators

LOS ANGELES- Beckley Academy, a prominent training organization specializing in the preparation of mental health professionals for psychedelic therapies, has announced the addition of two new facilitators to their team, Sara Gael Beauregard and Mary Sanders. Both bring a wealth of experience and expertise in psychedelic therapy, significantly enhancing the academy's capacity to train practitioners ...

December 15th, 2023|

Los Angeles Confronts Alarming Rise in Fentanyl-Related Fatal Overdoses

LOS ANGELES- In an alarming shift in the landscape of substance misuse, fentanyl has emerged as the leading cause of accidental overdose deaths in Los Angeles County, surpassing methamphetamine for the first time. According to a recent report from the L.A. County Department of Public Health, nearly 60% of overdose deaths in the area last ...

December 15th, 2023|

Arkansas’ Cannabis Revenues Generate Substantial Impact on Education and Community Welfare

LOS ANGELES- The newest review from the Arkansas Medical Marijuana Commission (AMMC) reveals the plan of the state's forward move to repurpose a sizeable sum of the revenue from the current upsurge of the state’s cannabis program. The most recent twist in the recent adaptation of fiscal structuring is poised to deliver a nourishing community-wide ...

December 14th, 2023|

Skymint’s Strategic Move Towards Long-term Viability Amidst Financial Struggles

  LOS ANGELES- Skymint, a leading cannabis operator in Michigan, is facing significant operational changes as it shuts down its Harvest Park growing and processing plant in Dimondale, near Lansing. The closure, announced in an internal memo obtained by Crain’s Detroit, is set to impact approximately 180 employees, with layoffs commencing on February 12 and ...

December 13th, 2023|

Illinois Cannabis Retailers Hit Record Sales in November

LOS ANGELES- November marked a historic month for Illinois' adult-use cannabis retailers, as they achieved the highest single-month sales of legal cannabis since the opening of weed shops in January 2020. The Illinois Department of Financial and Professional Regulation reported an impressive $139.1 million in total recreational cannabis sales. This figure breaks down into $105.5 ...

December 12th, 2023|

Arizona’s Cannabis Sales Show Signs of Stabilization

LOS ANGELES-Arizona's cannabis market, after experiencing a downturn over the summer, is showing signs of stabilization in the recent months, although overall sales for the year remain lower than expected. The state's cannabis industry has been navigating a fluctuating market, with the latest figures indicating a complex financial landscape. According to data from the Arizona ...

December 12th, 2023|

Cornell University Study Explores Hemp Cannabinoids as Potential Natural Pesticides

LOS ANGELES- Recent research conducted by scientists at Cornell University in New York has opened a new avenue in the study of hemp, suggesting that cannabinoids produced by the plant may serve as a source for developing natural pesticides. This study, undertaken by the School of Integrative Plant Science at Cornell AgriTech’s College of Agriculture ...

December 11th, 2023|

Optimi Health Corp. Partners with Sunshine Earth Labs to Supply Psychedelic Substances for Medicinal Research

LOS ANGELES- Optimi Health Corp. a Canadian company recognized for its work in controlled psychedelic substances such as natural psilocybin and MDMA, has announced a significant supply agreement with Sunshine Earth Labs Ltd., a British Columbia-based biosciences company also licensed by Health Canada. This strategic alliance highlights a commitment to supplying globally the Good Manufacturing ...

December 8th, 2023|

New York Intensifies Efforts to Combat Illicit Cannabis Shops with Increased Inspections and Seizures

LOS ANGELES- In a continued effort to regulate and control the cannabis market in New York, state agencies are intensifying their crackdown on illegal dispensaries. Alexander, in a recent press release, highlighted the importance of this initiative: “The number one remedy for the problem of these illicit shops is getting more legal businesses open. New ...

December 8th, 2023|

Psychedelics Industry Sees Surge in Business Activity Amid Push for Mainstream Acceptance

LOS ANGELES- The psychedelics industry is witnessing a remarkable surge in business deals, partnerships, and mergers, marking a significant shift toward mainstream acceptance and legitimacy. A staggering 500% increase in dealmaking over the past four years highlights the sector's rapid growth, as reported by the GlobalData Pharma Intelligence Center Deals Database. This uptick in business ...

December 7th, 2023|

New Jersey Considers Home Cultivation for Medical Cannabis Patients

LOS ANGELES- New Jersey is on the brink of a significant legislative change in its cannabis policy. A new bill has been introduced, aiming to legalize home cultivation of cannabis for registered medical cannabis patients. This move could mark a notable shift in the state's approach to cannabis, which currently allows both adult and medical ...

December 5th, 2023|

Florida’s Evolving Medical Cannabis Landscape: Trends and Future Prospects

LOS ANGELES - Florida’s medical cannabis market is witnessing significant growth, with over 850,000 active cannabis patients, representing about 4% of the state's population. Insights from the Brightfield Group’s U.S. Cannabis Consumer highlight several key trends shaping this burgeoning market. Demographic Trends Florida’s medical cannabis consumer base slightly differs from the national average. Notably, the ...

December 5th, 2023|
Go to Top